These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32715669)

  • 1. Proarrhythmogenic Effect of the L532P and N588K
    Heikhmakhtiar AK; Abrha AT; Jeong DU; Lim KM
    J Korean Med Sci; 2020 Jul; 35(29):e238. PubMed ID: 32715669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmic potency of human ether-a-go-go-related gene mutations L532P and N588K in a computational model of human atrial myocytes.
    Loewe A; Wilhelms M; Fischer F; Scholz EP; Dössel O; Seemann G
    Europace; 2014 Mar; 16(3):435-43. PubMed ID: 24569898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.
    Bodi I; Franke G; Pantulu ND; Wu K; Perez-Feliz S; Bode C; Zehender M; zur Hausen A; Brunner M; Odening KE
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1163-71. PubMed ID: 23718892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational analysis of the effect of KCNH2 L532P mutation on ventricular electromechanical behaviors.
    Heikhmakhtiar AK; Dusturia N; Lim KM
    J Electrocardiol; 2021; 66():24-32. PubMed ID: 33721574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of genetic mutations to atria vulnerability to atrial fibrillation: An in-silico 3D human atria study.
    Belletti R; Osca J; Romero Perez L; Saiz J
    Comput Methods Programs Biomed; 2024 Sep; 254():108307. PubMed ID: 38981143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
    Luo C; Wang K; Zhang H
    PLoS One; 2017; 12(6):e0179515. PubMed ID: 28632743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased vulnerability of human ventricle to re-entrant excitation in hERG-linked variant 1 short QT syndrome.
    Adeniran I; McPate MJ; Witchel HJ; Hancox JC; Zhang H
    PLoS Comput Biol; 2011 Dec; 7(12):e1002313. PubMed ID: 22194679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events.
    Ballouz S; Mangala MM; Perry MD; Heitmann S; Gillis JA; Hill AP; Vandenberg JI
    Cardiovasc Res; 2021 Aug; 117(10):2216-2227. PubMed ID: 33002116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of I(Kr) inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome.
    Cordeiro JM; Brugada R; Wu YS; Hong K; Dumaine R
    Cardiovasc Res; 2005 Aug; 67(3):498-509. PubMed ID: 16039272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
    Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
    Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenesis in the short-QT syndrome associated with combined HERG channel gating defects: a simulation study.
    Itoh H; Horie M; Ito M; Imoto K
    Circ J; 2006 Apr; 70(4):502-8. PubMed ID: 16565572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.
    Shinnawi R; Shaheen N; Huber I; Shiti A; Arbel G; Gepstein A; Ballan N; Setter N; Tijsen AJ; Borggrefe M; Gepstein L
    J Am Coll Cardiol; 2019 May; 73(18):2310-2324. PubMed ID: 31072576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computational method for identifying an optimal combination of existing drugs to repair the action potentials of SQT1 ventricular myocytes.
    Jæger KH; Edwards AG; Giles WR; Tveito A
    PLoS Comput Biol; 2021 Aug; 17(8):e1009233. PubMed ID: 34383746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-silico assessment of the dynamic effects of amiodarone and dronedarone on human atrial patho-electrophysiology.
    Loewe A; Lutz Y; Wilhelms M; Sinnecker D; Barthel P; Scholz EP; Dössel O; Schmidt G; Seemann G
    Europace; 2014 Nov; 16 Suppl 4():iv30-iv38. PubMed ID: 25362168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of the short QT N588K mutation at 37 degrees C on hERG K+ channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study.
    McPate MJ; Zhang H; Adeniran I; Cordeiro JM; Witchel HJ; Hancox JC
    J Physiol Pharmacol; 2009 Mar; 60(1):23-41. PubMed ID: 19439805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden death associated with short-QT syndrome linked to mutations in HERG.
    Brugada R; Hong K; Dumaine R; Cordeiro J; Gaita F; Borggrefe M; Menendez TM; Brugada J; Pollevick GD; Wolpert C; Burashnikov E; Matsuo K; Wu YS; Guerchicoff A; Bianchi F; Giustetto C; Schimpf R; Brugada P; Antzelevitch C
    Circulation; 2004 Jan; 109(1):30-5. PubMed ID: 14676148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression and Replacement Gene Therapy for
    Bains S; Zhou W; Dotzler SM; Martinez K; Kim CJ; Tester DJ; Ye D; Ackerman MJ
    Circ Genom Precis Med; 2022 Dec; 15(6):e003719. PubMed ID: 36252106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
    Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility.
    Odening KE; Bodi I; Franke G; Rieke R; Ryan de Medeiros A; Perez-Feliz S; Fürniss H; Mettke L; Michaelides K; Lang CN; Steinfurt J; Pantulu ND; Ziupa D; Menza M; Zehender M; Bugger H; Peyronnet R; Behrends JC; Doleschall Z; Zur Hausen A; Bode C; Jolivet G; Brunner M
    Eur Heart J; 2019 Mar; 40(10):842-853. PubMed ID: 30496390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in the KCNH2 gene associated with short QT syndrome.
    Sun Y; Quan XQ; Fromme S; Cox RH; Zhang P; Zhang L; Guo D; Guo J; Patel C; Kowey PR; Yan GX
    J Mol Cell Cardiol; 2011 Mar; 50(3):433-41. PubMed ID: 21130771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.